• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过用改良安卡拉痘苗病毒加强免疫增强疟疾DNA疫苗诱导CD8+ T细胞的免疫原性及完全保护效力。

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.

作者信息

Schneider J, Gilbert S C, Blanchard T J, Hanke T, Robson K J, Hannan C M, Becker M, Sinden R, Smith G L, Hill A V

机构信息

Institute of Molecular Medicine, Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, UK.

出版信息

Nat Med. 1998 Apr;4(4):397-402. doi: 10.1038/nm0498-397.

DOI:10.1038/nm0498-397
PMID:9546783
Abstract

Immunization with irradiated sporozoites can protect against malaria infection and intensive efforts are aimed at reproducing this effect with subunit vaccines. A particular sequence of subunit immunization with pre-erythrocytic antigens of Plasmodium berghei, consisting of single dose priming with plasmid DNA followed by a single boost with a recombinant modified vaccinia virus Ankara (MVA) expressing the same antigen, induced unprecedented complete protection against P. berghei sporozoite challenge in two strains of mice. Protection was associated with very high levels of splenic peptide-specific interferon-gamma-secreting CD8+ T cells and was abrogated when the order of immunization was reversed. DNA priming followed by MVA boosting may provide a general immunization regime for induction of high levels of CD8+ T cells.

摘要

用辐照子孢子进行免疫可预防疟疾感染,目前正致力于用亚单位疫苗重现这种效果。对伯氏疟原虫的红细胞前期抗原进行亚单位免疫的特定序列,即先用质粒DNA单剂量启动,然后用表达相同抗原的重组改良安卡拉痘苗病毒(MVA)进行单次加强免疫,在两株小鼠中诱导出了前所未有的针对伯氏疟原虫子孢子攻击的完全保护作用。这种保护作用与脾脏中高水平的肽特异性分泌干扰素-γ的CD8+T细胞有关,当免疫顺序颠倒时,这种保护作用就会消失。先用DNA启动,然后用MVA加强免疫,可能为诱导高水平的CD8+T细胞提供一种通用的免疫方案。

相似文献

1
Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.通过用改良安卡拉痘苗病毒加强免疫增强疟疾DNA疫苗诱导CD8+ T细胞的免疫原性及完全保护效力。
Nat Med. 1998 Apr;4(4):397-402. doi: 10.1038/nm0498-397.
2
Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models.基因枪皮内DNA免疫接种,随后用安卡拉改良痘苗病毒加强免疫:在流感和疟疾模型中增强CD8 + T细胞免疫原性和保护效力。
Vaccine. 1999 Nov 12;18(7-8):623-32. doi: 10.1016/s0264-410x(99)00278-9.
3
Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus.使用新型减毒鸡痘病毒的初免-加强免疫方案引发针对伯氏疟原虫疟疾的增强的CD8 + T细胞免疫反应和保护作用。
J Immunol. 2004 Mar 1;172(5):3094-100. doi: 10.4049/jimmunol.172.5.3094.
4
IL-12p40-independent induction of protective immunity upon multiple Plasmodium berghei irradiated sporozoite immunizations.多次伯氏疟原虫辐照子孢子免疫后不依赖白细胞介素-12p40诱导保护性免疫
Parasite Immunol. 2007 Nov;29(11):541-8. doi: 10.1111/j.1365-3024.2007.00972.x.
5
Immunogenicity of Ty-VLP bearing a CD8(+) T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus.携带约氏疟原虫CS蛋白CD8(+) T细胞表位的Ty-VLP的免疫原性:通过重组痘苗病毒加强免疫增强记忆反应
Vaccine. 2000 Mar 6;18(17):1863-9. doi: 10.1016/s0264-410x(99)00344-8.
6
Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations.DNA初免和痘病毒加强免疫诱导的疟疾保护性免疫的持久性:效应和记忆CD8(+) T细胞群体的特征
Infect Immun. 2002 Jul;70(7):3493-9. doi: 10.1128/IAI.70.7.3493-3499.2002.
7
Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus.提高基于DNA免疫诱导的保护性免疫:用编码抗原和GM-CSF的质粒DNA进行初次免疫,并用表达抗原的重组痘病毒进行加强免疫。
J Immunol. 2000 Jun 1;164(11):5905-12. doi: 10.4049/jimmunol.164.11.5905.
8
Induction of protective immunity against malaria by priming-boosting immunization with recombinant cold-adapted influenza and modified vaccinia Ankara viruses expressing a CD8+-T-cell epitope derived from the circumsporozoite protein of Plasmodium yoelii.用表达源自约氏疟原虫环子孢子蛋白的CD8 + T细胞表位的重组冷适应流感病毒和改良痘苗安卡拉病毒进行初免-加强免疫诱导抗疟疾保护性免疫。
J Virol. 2003 Nov;77(21):11859-66. doi: 10.1128/jvi.77.21.11859-11866.2003.
9
Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes.在小鼠疟疾模型中,使用重组腺病毒疫苗进行异源初免-加强免疫方案时增强的CD8 T细胞免疫原性和保护效力。
Vaccine. 2002 Jan 15;20(7-8):1039-45. doi: 10.1016/s0264-410x(01)00450-9.
10
Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations.Ty病毒样颗粒、DNA疫苗与安卡拉痘苗病毒;比较与联合应用
Biol Chem. 1999 Mar;380(3):299-303. doi: 10.1515/BC.1999.041.

引用本文的文献

1
Immunogenic recombinant Mayaro virus-like particles present natively assembled glycoprotein.具有免疫原性的重组马亚罗病毒样颗粒呈现天然组装的糖蛋白。
NPJ Vaccines. 2024 Dec 17;9(1):243. doi: 10.1038/s41541-024-01021-9.
2
Combined intranasal and intramuscular parainfluenza 5-, simian adenovirus ChAdOx1- and poxvirus MVA-vectored vaccines induce synergistically HIV-1-specific T cells in the mucosa.联合鼻内和肌肉内接种副流感 5 型、猴腺病毒 ChAdOx1 和痘病毒 MVA 载体疫苗可在黏膜中诱导协同的 HIV-1 特异性 T 细胞。
Front Immunol. 2023 Jul 17;14:1186478. doi: 10.3389/fimmu.2023.1186478. eCollection 2023.
3
Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models.
表达预融合稳定型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突糖蛋白的痘苗病毒株MVA在小鼠和仓鼠模型中诱导强大的保护作用并预防脑部感染。
Vaccines (Basel). 2023 May 21;11(5):1006. doi: 10.3390/vaccines11051006.
4
Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications.基于安卡拉改良痘苗病毒疫苗的研发:优势与应用
Vaccines (Basel). 2022 Sep 13;10(9):1516. doi: 10.3390/vaccines10091516.
5
Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies.病毒样颗粒是增强 mRNA 诱导抗体的有效工具。
Front Immunol. 2022 Jun 16;13:864718. doi: 10.3389/fimmu.2022.864718. eCollection 2022.
6
Extracellular Vesicles and Their Use as Vehicles of Immunogens.细胞外囊泡及其作为免疫原载体的用途。
Methods Mol Biol. 2022;2504:177-198. doi: 10.1007/978-1-0716-2341-1_13.
7
Development of Viral-Vectored Vaccines and Virus Replicon Particle-Based Neutralisation Assay against Mayaro Virus.开发针对 Mayaro 病毒的病毒载体疫苗和基于病毒复制子颗粒的中和测定法。
Int J Mol Sci. 2022 Apr 7;23(8):4105. doi: 10.3390/ijms23084105.
8
Win or loss? Combination therapy does improve the oncolytic virus therapy to pancreatic cancer.胜或负?联合疗法确实能改善溶瘤病毒对胰腺癌的治疗效果。
Cancer Cell Int. 2022 Apr 20;22(1):160. doi: 10.1186/s12935-022-02583-1.
9
Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients.同源与异源加强对 Ad26.COV2.S 疫苗接种者的免疫原性差异。
Med. 2022 Feb 11;3(2):104-118.e4. doi: 10.1016/j.medj.2021.12.004. Epub 2022 Jan 19.
10
Developmental Landscape of Potential Vaccine Candidates Based on Viral Vector for Prophylaxis of COVID-19.基于病毒载体的 COVID-19 预防用潜在候选疫苗的研发前景
Front Mol Biosci. 2021 Apr 15;8:635337. doi: 10.3389/fmolb.2021.635337. eCollection 2021.